These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21438851)

  • 1. Prevention and treatment of diabetic retinopathy: evidence from clinical trials and perspectives.
    Abbate M; Cravedi P; Iliev I; Remuzzi G; Ruggenenti P
    Curr Diabetes Rev; 2011 May; 7(3):190-200. PubMed ID: 21438851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches to the treatment of diabetic retinopathy.
    Porta M; Maldari P; Mazzaglia F
    Diabetes Obes Metab; 2011 Sep; 13(9):784-90. PubMed ID: 21535345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy.
    Sjølie AK; Chaturvedi N
    J Hum Hypertens; 2002 Aug; 16 Suppl 3():S42-6. PubMed ID: 12140727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the treatment of diabetic retinopathy.
    Yam JC; Kwok AK
    Hong Kong Med J; 2007 Feb; 13(1):46-60. PubMed ID: 17277392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving microvascular outcomes in patients with diabetes through management of hypertension.
    McGill JB
    Postgrad Med; 2009 Mar; 121(2):89-101. PubMed ID: 19332966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management of diabetic retinopathy: an overview.
    Malek M; Khamseh ME; Aghili R; Emami Z; Najafi L; Baradaran HR
    Arch Iran Med; 2012 Oct; 15(10):635-40. PubMed ID: 23020540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospects for angiotensin receptor blockers in diabetic retinopathy.
    Sjølie AK
    Diabetes Res Clin Pract; 2007 May; 76 Suppl 1():S31-9. PubMed ID: 17321627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing role of the endocrinologist in the care of patients with diabetic retinopathy.
    Porta M; Taulaigo AV
    Endocrine; 2014 Jun; 46(2):199-208. PubMed ID: 24385265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond.
    Clermont A; Bursell SE; Feener EP
    J Hypertens Suppl; 2006 Mar; 24(1):S73-80. PubMed ID: 16601577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches and perspectives in the medical treatment of diabetic retinopathy.
    Porta M; Allione A
    Pharmacol Ther; 2004 Aug; 103(2):167-77. PubMed ID: 15369682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis.
    Wang B; Wang F; Zhang Y; Zhao SH; Zhao WJ; Yan SL; Wang YG
    Lancet Diabetes Endocrinol; 2015 Apr; 3(4):263-74. PubMed ID: 25660574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic implications of renin-angiotensin system blockade in diabetic retinopathy.
    Jeganathan VS
    Curr Pharm Biotechnol; 2011 Mar; 12(3):392-5. PubMed ID: 20939795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of diabetic retinopathy and the renin-angiotensin system.
    Funatsu H; Yamashita H
    Ophthalmic Physiol Opt; 2003 Nov; 23(6):495-501. PubMed ID: 14622351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic retinopathy.
    Grassi G
    Minerva Med; 2003 Dec; 94(6):419-35. PubMed ID: 14976470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction between the renin-angiotensin system and vascular endothelial growth factor in the pathogenesis of retinal neovascularization in diabetes.
    Wilkinson-Berka JL; Kelly DJ; Gilbert RE
    J Vasc Res; 2001; 38(6):527-35. PubMed ID: 11740151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the treatment of diabetic retinopathy.
    Wilkinson-Berka JL; Miller AG
    ScientificWorldJournal; 2008 Feb; 8():98-120. PubMed ID: 18264628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic retinopathy: treatment and prevention.
    Dodson PM
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S9-S11. PubMed ID: 17935059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventing blindness due to diabetic retinopathy. Control glycaemia and blood pressure, and monitor the eyes.
    Prescrire Int; 2010 Feb; 19(105):35-8. PubMed ID: 20455344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of diabetic retinopathy: evidence from large, randomized trials. The emerging role of fenofibrate.
    Simó R; Hernández C
    Rev Recent Clin Trials; 2012 Feb; 7(1):71-80. PubMed ID: 21864248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.